SEC Filings

SEC Filings

Filing date	Description	Form	View
Jul 31, 2013	Form of prospectus reflecting facts events constituting substantive change from last form	424B3	View HTML 0001193125-13-311436.pdf 0001193125-13-311436.rtf 0001193125-13-311436.xls
Jul 25, 2013	Report of unscheduled material events or corporate event	8-K	View HTML 0001193125-13-302712.pdf 0001193125-13-302712.rtf 0001193125-13-302712.xls
Jul 18, 2013	Report of unscheduled material events or corporate event	8-K	View HTML 0001193125-13-294288.pdf 0001193125-13-294288.rtf 0001193125-13-294288.xls
Jun 05, 2013	Report of unscheduled material events or corporate event	8-K	View HTML 0001193125-13-248665.pdf 0001193125-13-248665.rtf 0001193125-13-248665.xls
Jun 04, 2013	Statement of changes in beneficial ownership of securities	4	View HTML 0001181431-13-032585.pdf 0001181431-13-032585.rtf
Jun 04, 2013	Statement of changes in beneficial ownership of securities	4	View HTML 0001181431-13-032584.pdf 0001181431-13-032584.rtf
Jun 04, 2013	Statement of changes in beneficial ownership of securities	4	View HTML 0001181431-13-032583.pdf 0001181431-13-032583.rtf
Jun 04, 2013	Statement of changes in beneficial ownership of securities	4	View HTML 0001181431-13-032587.pdf 0001181431-13-032587.rtf
Jun 04, 2013	Statement of changes in beneficial ownership of securities	4	View HTML 0001181431-13-032586.pdf 0001181431-13-032586.rtf
May 17, 2013	Report of unscheduled material events or corporate event	8-K	View HTML 0001193125-13-225074.pdf 0001193125-13-225074.rtf 0001193125-13-225074.xls

Data provided by Kaleidoscope.

For investor inquiries, please contact:

ReShape Lifesciences Investor Contact:
Thomas Stankovich
Chief Financial Officer
949-276-6042
ir@ReShapeLifesci.com

Investor Contacts:
Rx Communications Group
Michael Miller
917-633-6086
mmiller@rxir.com

PRINT PAGE

EMAIL PAGE